Black Cohosh Does Not Bind to Estrogen Receptors or Upregulate Estrogen-Dependent Genes
The correct statement is (a): Black cohosh extracts do NOT bind to estrogen receptors or upregulate estrogen-dependent genes. This has been definitively demonstrated through multiple mechanistic assays, and the mechanism of action appears to be serotonergic rather than estrogenic 1, 2.
Evidence for Non-Estrogenic Mechanism
Research using RNAse protection assays, estrogen-responsive-element (ERE)-luciferase assays, and ER-expressing breast cancer cell systems has conclusively shown that black cohosh extracts do not demonstrate estrogenic activity 1. The plant works through serotonergic pathways, not estrogen receptor binding 2.
Why the Other Statements Are Incorrect
Statement (b) - Comparability to HRT: FALSE
The 2015 Endocrine Society guidelines explicitly state there is a "lack of consistent evidence for benefit for botanicals, black cohosh" 3. When directly compared to hormone therapy, HRT significantly outperforms black cohosh:
- HRT reduces daily hot flush frequency more effectively than black cohosh (three trials) 4
- HRT produces better menopausal symptom scores (SMD 0.32; 95% CI 0.13 to 0.51) 4
Black cohosh is NOT comparable to hormone replacement therapy in efficacy.
Statement (c) - Generic Extracts: FALSE
Research has primarily evaluated specific standardized extracts, particularly the isopropanolic extract at 40 mg/day 5. The most well-designed studies use standardized preparations, not generic extracts 5.
Statement (d) - Effects on Hormone Levels: FALSE
Black cohosh does not clinically affect levels of estradiol, luteinizing hormone, or follicle-stimulating hormone 1. Its mechanism is serotonergic, not hormonal 2.
Clinical Bottom Line
Black cohosh may provide modest benefit for vasomotor symptoms (hot flashes) with a small effect size (Hedges' g = 0.315) 6, but the Endocrine Society guidelines note "inconsistent efficacy over placebo" 3. The 2012 Cochrane review found no significant difference between black cohosh and placebo for hot flush frequency (MD 0.07 flushes per day; 95% CI -0.43 to 0.56) 4.
Important Safety Caveat
Be aware of serotonin toxicity risk: Black cohosh has serotonergic properties and can cause serotonin toxicity and rhabdomyolysis when combined with antidepressants (SSRIs/SNRIs) 7. This is a critical drug interaction that patients often don't recognize since black cohosh is an over-the-counter supplement.